MBDA has successfully carried out the first qualification firing trial of the Sea Venom/ANL anti-ship missile at the DGA Essais de missiles (DGA EM) test site at Ile Du Levant on 20 February 2020, another significant milestone for the Anglo-French co-operation program.
The missile was launched from a Dauphin helicopter close to the minimum release height, reaching its cruise phase whilst sea skimming at very low height. During its terminal phase, the aircrew used images from the infrared seeker - transmitted through the datalink - to perform a successful manual aim point refinement. The missile has then followed this designated point until hitting the target with a very high degree of accuracy.
This latest firing builds on two previous ones that have all tested the missile to the very edge of its capability. The previous firings demonstrated Sea Venom/ANL’s lock on after launch (LOAL) and lock on before launch (LOBL) capabilities. They also validated its low-altitude sea-skimming flight and its autonomous guidance capability using images from its uncooled imaging infrared (IIR) seeker.
Sea Venom/ANL is a purpose-built anti-ship missile for the French and UK navies’ shipborne helicopters, and is suitable for a wide range of platforms. It will safely engage hostile vessels amongst civilian assets, even in congested littoral environments and will defeat a broad spectrum of targets including small fast-moving craft through to larger ships – at sea or in port – as well as coastal land targets.
Éric Béranger, MBDA CEO, said: “Sea Venom/ANL is the first Anglo-French co-operation program to take full advantage of our centers of excellence, created following an Inter-Governmental Agreement ratified by both nations’ Parliaments in 2016. MBDA is putting full effort into the successful implementation of the Sea Venom/ANL program, recognizing it should exemplify the benefits of the close co-operation UK and France are sharing in defense – enhancing both nation’s sovereign capabilities in armaments while reducing costs.”
The UK Royal Navy will use Sea Venom/ANL on its AW159 Wildcat, replacing Sea Skua, while France’s Marine Nationale will operate the missile from its future Guépard Light Joint Helicopter (HIL – Hélicoptère Interarmées Léger).
The UK and France are jointly developing Sea Venom/ANL under a program launched at the 2010 Lancaster House Summit. It has played a key part in the creation of, and is the first program to take full advantage of, shared centers of excellence on missile technologies created within the Anglo-French missile industry under the ‘One Complex Weapons’ initiative, a move that provides significant benefits to both nations.
MBDA is the only European group capable of designing and producing missiles and missile systems that correspond to the full range of current and future operational needs of the three armed forces (land, sea and air).
With a significant presence in five European countries and within the USA, in 2018 MBDA achieved revenue of 3.2 billion Euros with an order book of 17.4 billion Euros. With more than 90 armed forces customers in the world, MBDA is a world leader in missiles and missile systems. In total, the group offers a range of 45 missile systems and countermeasures products already in operational service and more than 15 others currently in development.
MBDA is jointly owned by Airbus (37.5 %), BAE Systems (37.5 %), and Leonardo (25 %).
